Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations
media
posted on 2021-06-10, 15:59 authored by Adis Rapid Journals on behalf of:, Jerry Li, Dana Nickens, Keith Wilner, Weiwei Tan<p><strong>Article full
text</strong></p>
<p><br></p><p>
The above summary slide represents the opinions of
the <b>authors</b>. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC <b>2021.</b></p>
